ArticleClinical pharmacology in drug development2022

Clinical Pharmacokinetics and Safety of a 10% Aminolevulinic Acid Hydrochloride Nanoemulsion Gel (BF-200 ALA) in Photodynamic Therapy of Patients Extensively Affected With Actinic Keratosis: Results of 2 Maximal Usage Pharmacokinetic Trials.

Ben Novak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.